mammaprint
![MammaPrint® - Agendia’s Risk Of Recurrence Test](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint® - Agendia’s Risk Of Recurrence Test
![Genomic testing in early breast cancer: MammaPrint & BluePrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Genomic testing in early breast cancer: MammaPrint & BluePrint
![Genomic Profiling in early stage breast cancer & Role of Mammaprint & Blueprint testing | Oncquest](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Genomic Profiling in early stage breast cancer & Role of Mammaprint & Blueprint testing | Oncquest
![Patient Experiences with MammaPrint®](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Patient Experiences with MammaPrint®
![Dr. Soliman on Impact of MammaPrint in Patients With Early-Stage Breast Cancer](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Dr. Soliman on Impact of MammaPrint in Patients With Early-Stage Breast Cancer
![Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT
![Comparing MammaPrint to Oncotype Dx](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Comparing MammaPrint to Oncotype Dx
![MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients
![Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy
![Introduction and Walkthrough: Summary of Results for MammaPrint and BluePrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Introduction and Walkthrough: Summary of Results for MammaPrint and BluePrint
![The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
The 70-gene signature (MammaPrint) accurately predicts distant breast cancer recurrence
![How MammaPrint and BluePrint Reclassifies Tumors Based on Tumor Biology, Ian Grady, MD FACS](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
How MammaPrint and BluePrint Reclassifies Tumors Based on Tumor Biology, Ian Grady, MD FACS
![Combining Pathology, MammaPrint and BluePrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Combining Pathology, MammaPrint and BluePrint
![How to place an order for MammaPrint and BluePrint using the online portal (EN)](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
How to place an order for MammaPrint and BluePrint using the online portal (EN)
![MammaPrint® & BluePrint®](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint® & BluePrint®
![MammaPrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint
![MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br...](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br...
![Beth DuPree, MD FACS ABOHM Statement On Genomic Testing, MammaPrint & BluePrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Beth DuPree, MD FACS ABOHM Statement On Genomic Testing, MammaPrint & BluePrint
![Short Review: General Overview of Invasive Ductal Carcinoma (Breast)](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Short Review: General Overview of Invasive Ductal Carcinoma (Breast)
![Predicting Progression of DCIS to Invasive Cancer](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Predicting Progression of DCIS to Invasive Cancer
![The Use of Genomic MammaPrint BluePrint in Neoadjuvant Breast Cancer Dr James Pellicane](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
The Use of Genomic MammaPrint BluePrint in Neoadjuvant Breast Cancer Dr James Pellicane
![TESTY GENETYCZNE- MammaPrint i BluePrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
TESTY GENETYCZNE- MammaPrint i BluePrint
![MammaPrint- de duidelijkheid wanneer je die het hardst nodig hebt](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint- de duidelijkheid wanneer je die het hardst nodig hebt
![Carmen's Story](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Carmen's Story
![The Role of BRCA1 in Cancer](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
The Role of BRCA1 in Cancer
![Latonya's Story - Don't Lump Me In](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Latonya's Story - Don't Lump Me In
![Beth DuPree, MD FACS ABOHM Presents Case Study On 50yr Female With Invasive Ductal Carcinoma, Grade3](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Beth DuPree, MD FACS ABOHM Presents Case Study On 50yr Female With Invasive Ductal Carcinoma, Grade3
![MammaPrint Identifies Which Breast Cancer Patients Can Bypass Chemotherapy](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint Identifies Which Breast Cancer Patients Can Bypass Chemotherapy
![Pronounce Medical Words ― MammaPrint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Pronounce Medical Words ― MammaPrint
![Genomic Testing in Breast Cancer: What You Must Know](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Genomic Testing in Breast Cancer: What You Must Know
![Dealing with an "intermediate" breast cancer recurrence score?](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Dealing with an "intermediate" breast cancer recurrence score?
![Will I need Chemotherapy for My Breast Cancer?](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Will I need Chemotherapy for My Breast Cancer?
![Artsen vertellen over de MammaPrint - Thijs van Dalen](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Artsen vertellen over de MammaPrint - Thijs van Dalen
![Short Documentary](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Short Documentary
![Genomic assay performance: core needle biopsy vs. surgical resection samples](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Genomic assay performance: core needle biopsy vs. surgical resection samples
![Beating Breast Cancer Without Chemo, Radiation or Tamoxifen](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Beating Breast Cancer Without Chemo, Radiation or Tamoxifen
![Adam Brufsky, MD - University of Pittsburgh Medical Center](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Adam Brufsky, MD - University of Pittsburgh Medical Center
![Mammaprint en la toma de decisiones clínicas en Ca de mama temprano actualización 2021](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Mammaprint en la toma de decisiones clínicas en Ca de mama temprano actualización 2021
![Aleseia's Story](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Aleseia's Story
![The management of breast cancer in the Japanese population](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
The management of breast cancer in the Japanese population
![Cutting Edge Advances in Breast Cancer Treatment:](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Cutting Edge Advances in Breast Cancer Treatment:
![Jennifer Tittensor, MD FACS Presents Case Study On Low Risk, 76 Yr Patient, Large Tumor-mammogram](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Jennifer Tittensor, MD FACS Presents Case Study On Low Risk, 76 Yr Patient, Large Tumor-mammogram
![Poster comparing Oncotype dx and Mammaprint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Poster comparing Oncotype dx and Mammaprint
![MammaPrint Study Spares Breast Cancer Patients Chemo](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint Study Spares Breast Cancer Patients Chemo
![Genomic Profiling of Breast Cancer in African-American Women](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Genomic Profiling of Breast Cancer in African-American Women
![MINDACT: adjuvant chemotherapy in breast cancer](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MINDACT: adjuvant chemotherapy in breast cancer
![CÂNCER DE MAMA | Como definir quem precisa de quimioterapia? Exames de Oncotype e Mammaprint](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
CÂNCER DE MAMA | Como definir quem precisa de quimioterapia? Exames de Oncotype e Mammaprint
![CÂNCER DE MAMA | Como saber se é necessário quimioterapia depois da cirurgia? Mammaprint e Oncotype](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
CÂNCER DE MAMA | Como saber se é necessário quimioterapia depois da cirurgia? Mammaprint e Oncotype
![Individuelles Risiko – Therapie nach Maß; MammaPrint + BluePrint – Mehr wissen, besser entscheiden!“](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Individuelles Risiko – Therapie nach Maß; MammaPrint + BluePrint – Mehr wissen, besser entscheiden!“
![Beneficios del uso de Mammaprint+Blueprint en cáncer de mama](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Beneficios del uso de Mammaprint+Blueprint en cáncer de mama
![MammaPrint®, el análisis genómico del riesgo de recaída para cáncer de mama](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
MammaPrint®, el análisis genómico del riesgo de recaída para cáncer de mama
![Jennifer Tittensor, MD FACS Presents Case Study On Why MammaPrint And BluePrint Is So Important](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Jennifer Tittensor, MD FACS Presents Case Study On Why MammaPrint And BluePrint Is So Important
![ONN Preview: Priority Review in Ovarian Cancer, Mixed Results in Myelofibrosis, and More](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
ONN Preview: Priority Review in Ovarian Cancer, Mixed Results in Myelofibrosis, and More
![Neoadjuvant Endocrine Therapy in Breast Cancer](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Neoadjuvant Endocrine Therapy in Breast Cancer
![Experts Comment, Agendia Breast Cancer Assays - Phillip Ley, MD](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Experts Comment, Agendia Breast Cancer Assays - Phillip Ley, MD
![The Latest: What To Do If You Have An Intermediate Oncotype Recurrence Score](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
The Latest: What To Do If You Have An Intermediate Oncotype Recurrence Score
![Molecular Subtyping with Breast Cancer](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Molecular Subtyping with Breast Cancer
![[ Ep.12 ] 유방암 항암치료 여부를 결정하는 맘마프린트 검사](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
[ Ep.12 ] 유방암 항암치료 여부를 결정하는 맘마프린트 검사
![Priority Review in Ovarian Cancer, Rolling Submission in ALK-Positive NSCLC, and More](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Priority Review in Ovarian Cancer, Rolling Submission in ALK-Positive NSCLC, and More
![Jennifer Tittensor, MD FACS Presents The Benefits Of BluePrint, Molecular Subtype Assay](https://www.seevid.ir/assets/images/thumbnail_medium_en.avif)
Jennifer Tittensor, MD FACS Presents The Benefits Of BluePrint, Molecular Subtype Assay